CA2588564A1 - Acides nucleiques et proteines correspondantes designes par 158p3d2, et pouvant etre employes dans le traitement et la detection de cancers - Google Patents

Acides nucleiques et proteines correspondantes designes par 158p3d2, et pouvant etre employes dans le traitement et la detection de cancers Download PDF

Info

Publication number
CA2588564A1
CA2588564A1 CA002588564A CA2588564A CA2588564A1 CA 2588564 A1 CA2588564 A1 CA 2588564A1 CA 002588564 A CA002588564 A CA 002588564A CA 2588564 A CA2588564 A CA 2588564A CA 2588564 A1 CA2588564 A1 CA 2588564A1
Authority
CA
Canada
Prior art keywords
protein
cancer
cell
amino acid
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002588564A
Other languages
English (en)
Inventor
Arthur B. Raitano
Aya Jakobovits
Pia M. Challita-Eid
Steven B. Kanner
Wangmao Ge
Juan J. Perez-Villar
Robert Kendall Morrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agensys Inc
Original Assignee
Agensys, Inc.
Arthur B. Raitano
Aya Jakobovits
Pia M. Challita-Eid
Steven B. Kanner
Wangmao Ge
Juan J. Perez-Villar
Robert Kendall Morrison
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agensys, Inc., Arthur B. Raitano, Aya Jakobovits, Pia M. Challita-Eid, Steven B. Kanner, Wangmao Ge, Juan J. Perez-Villar, Robert Kendall Morrison filed Critical Agensys, Inc.
Publication of CA2588564A1 publication Critical patent/CA2588564A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002588564A 2004-11-19 2004-11-19 Acides nucleiques et proteines correspondantes designes par 158p3d2, et pouvant etre employes dans le traitement et la detection de cancers Abandoned CA2588564A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/039083 WO2006055004A1 (fr) 2004-11-19 2004-11-19 Acides nucléiques et protéines correspondantes désignés par 158p3d2, et pouvant être employés dans le traitement et la détection de cancers

Publications (1)

Publication Number Publication Date
CA2588564A1 true CA2588564A1 (fr) 2006-05-26

Family

ID=34959621

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002588564A Abandoned CA2588564A1 (fr) 2004-11-19 2004-11-19 Acides nucleiques et proteines correspondantes designes par 158p3d2, et pouvant etre employes dans le traitement et la detection de cancers

Country Status (3)

Country Link
EP (1) EP1824877A1 (fr)
CA (1) CA2588564A1 (fr)
WO (1) WO2006055004A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11318163B2 (en) 2015-02-18 2022-05-03 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11000548B2 (en) 2015-02-18 2021-05-11 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
IL297418B2 (en) 2015-02-18 2023-11-01 Enlivex Therapeutics Rdo Ltd Combined immunotherapy and cytokine control therapy for cancer treatment
US11596652B2 (en) 2015-02-18 2023-03-07 Enlivex Therapeutics R&D Ltd Early apoptotic cells for use in treating sepsis
US11304976B2 (en) 2015-02-18 2022-04-19 Enlivex Therapeutics Ltd Combination immune therapy and cytokine control therapy for cancer treatment
US11497767B2 (en) 2015-02-18 2022-11-15 Enlivex Therapeutics R&D Ltd Combination immune therapy and cytokine control therapy for cancer treatment
EP3285877B1 (fr) 2015-04-21 2022-10-19 Enlivex Therapeutics Rdo Ltd Préparations thérapeutiques à base de cellules apoptotiques sanguines regroupées et leurs utilisations
AU2017219415B2 (en) 2016-02-18 2023-08-10 Enlivex Therapeutics Rdo Ltd Combination immune therapy and cytokine control therapy for cancer treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1383922A4 (fr) * 2001-04-10 2005-03-30 Agensys Inc Acide nucleique et proteine correspondante intitule 158p3d2 utiles dans le traitement et la detection du cancer

Also Published As

Publication number Publication date
WO2006055004A1 (fr) 2006-05-26
EP1824877A1 (fr) 2007-08-29
WO2006055004A8 (fr) 2006-09-28

Similar Documents

Publication Publication Date Title
US8853364B2 (en) Prostate stem cell antigen (PSCA) variants and subsequences thereof
US8426571B2 (en) Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
AU2002361610B2 (en) Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
US7968090B2 (en) Nucleic acids and corresponding proteins entitled 191P4D12(b) useful in treatment and detection of cancer
CA2481503A1 (fr) Acide nucleique et proteine correspondante 98p4b6 utilises dans le traitement et la detection du cancer
AU2010200938B2 (en) Nucleic acids and corresponding proteins entitled 58P1D12 useful in treatment and detection of cancer
US20110086437A1 (en) Methods to inhibit cell growth
US20110008393A1 (en) Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer
CA2522994C (fr) Acides nucleiques et proteines correspondantes appelees 109p1d4 utiles dans le traitement et la detection du cancer
US7811575B2 (en) Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer
CA2514058A1 (fr) Acides nucleiques et proteines correspondantes dites 254p1d6b utiles pour la detection et le traitement du cancer
CA2515699C (fr) Acide nucleique et proteine correspondante dite 158p1d7, utiles pour le traitement et la detection de cancers de la vessie et autres
CA2588564A1 (fr) Acides nucleiques et proteines correspondantes designes par 158p3d2, et pouvant etre employes dans le traitement et la detection de cancers
CA2503346A1 (fr) Acide nucleique 24p4c12 et proteine correspondante utilises dans le traitement et la detection du cancer
CA2496566A1 (fr) Acide nucleique et proteine correspondante denommes 98p4b6, pour traitement et detection du cancer
AU2007216892A1 (en) Nucleic acids and corresponding proteins entitled 273P4B7 useful in treatment and detection of cancer

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20150424